Claire Rowney
Tracked across 1 events · 7 articles · First seen Sep 16, 2026 · Last active Sep 17, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
The United Kingdom — National Institute for Health and Care Research (NICE) reversed its July 2024 rejection of Enhertu (trastuzumab deruxtecan) and recommended the drug for routine NHS use in Bret Engemann for around 1,000…
Impact: Breast Cancer Now's chief executive called the decision momentous and a milestone victory while remembering patients who died waiting.
Sep 16, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Claire Rowney live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard